← Back
BridgeBio Pharma, Inc.
BBIO
$65.04-2.20%
SEC Filings
Recommended10-Q · Aug 10, 2026
Not sure where to start? This is BridgeBio Pharma, Inc.'s most recent filing. Start with its AI summary.
10-QRecommendedAug 10, 2026
10-QMay 7, 2026
10-KFeb 24, 2026
10-QOct 29, 2025
10-QAug 5, 2025
10-QApr 29, 2025
10-KFeb 20, 2025
10-QNov 12, 2024
10-QAug 1, 2024
10-QMay 2, 2024
Showing filings since Nov 4, 2021. Full history on SEC EDGAR